Tag: Cancer: Lung
Radiotherapy Dose to Cardiac Substructures Linked to Arrhythmias
After adjustment for baseline cardiovascular risk, pulmonary vein volume receiving 5 Gy linked to atrial fibrillation
Alternative Criteria Can ID High-Benefit Groups for Lung Cancer Screening
Alternative criteria included people who smoked any amount for at least 40 years; people aged 60 to 80 years with 40 pack-years of smoking
Rheumatoid Arthritis Tied to Higher Risk for Lung Cancer
Rheumatoid arthritis-interstitial lung disease shows particularly high risk
Most Americans Don’t Know About Lung Cancer Screening: Survey
Intensity-Modulated Radiotherapy Recommended for Locally Advanced Lung Cancer
Patients receiving IMRT and three-dimensional conformal radiotherapy appear to have similar rates of developing secondary cancer
E-Cigarette Use Linked to Lower Use of Lung Cancer Screening
Similar findings seen for those who previously used combustible cigarettes and currently use electronic cigarettes
Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung Cancer
Improved progression-free survival seen for amivantamab-lazertinib versus osimertinib as first-line treatment
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is Low
Increase in UTD-LCS prevalence seen with age and number of comorbidities; relatively lower levels seen in Southern states
Lung Cancer Screening Increases Earlier-Stage Diagnoses, Improves Survival
Uptake of lung cancer screening was low, but overall and lung cancer-specific survival improved with screening
ASCO: Ivonescimab Improves Progression-Free Survival in EGFR+ Lung Cancer
PFS benefit seen in most subgroups, including those whose disease progressed while receiving third-generation EGFR-TKIs
